Fast-Food Money FastTim Hortons, the largest fast-food chain in Canada with 27.7% of the market based on traffic, is going public this week, Jim Cramer told "Mad Money" viewers Monday. And he believes that it's a chance to make some mad money fast. "How can I tell beforehand that when this stock starts trading it should go up?" he asked. "It's all about the roadshow." "Think of the road show as a mini-Broadway play that's all about pimping the stock. ... And just like a Broadway show, it starts in the so-called provinces and then ends in New York," Cramer said. Cramer said that Wall Street firms interested in buying the stock send a "face person" to the roadshow, because they are sure to get a better allocation at the IPO if they sign in. And the more people that show up, the more interest there is in the stock. "The headcount for Tim Hortons was off the charts," he said. The price range is at $18 to $20 a share, but Cramer also believes that the underwriters are going to have to raise that range. "And when you get bump after bump in the price range, that's a fabulous sign that you have to be in," he said. But how do you make money off of this IPO? Tim Hortons, which will trade on the NYSE under the symbol THI, will not be a cheap stock, he said. And it certainly won't be cheap if it goes to $28, which is where Cramer expects it to go, given the success of Chipotle ( CMG). But a stock is only cheap or expensive relative to where it's going, he reminded viewers, adding that "this stock is going higher." Plus, he said that we know there's strong demand, but a small float, meaning that not many shares will be offered.
Who's So Vain?Finally, Cramer has said again and again that there's money to be made in the vanity of baby boomers. "The wheels of capitalism are greased by good-looking skin," said Cramer. And with that, he welcomed Jonah Shacknai, chairman and chief executive of Medicis Pharmaceutical ( MRX). Shacknai said that the wrinkle treatment Reloxin, which already has a strong market position overseas, should boost his company's bottom line. Under a new deal that became effective today, Medicis now has rights to develop, distribute and market the botulinum toxin product in the U.S., Canada and Japan. Shacknai said that his company won the battle for the distribution rights to Reloxin because Medicis believes strongly in the product. Cramer pointed out that some analysts said that the last quarter was lackluster, but Shacknai said that it's all about "performance in the current scheme of things." To view Cramer's interview with Shacknai,
BullishCramer was bullish on Rent-A-Center ( RCII), Conexant Systems ( CNXT), Wal-Mart ( WMT), Rambus ( RMBS), Ericsson ( ERICY), Cameco ( CCJ), GameStop ( GME), Triad Hospitals ( TRI), Halliburton ( HAL), Nabors ( NBR) Cendant ( CD), Vodafone ( VOD), Alcan ( AL), Powerwave Technologies ( PWAV), Marathon Oil ( MRO), Ultra Petroleum ( UPL), ConocoPhillips ( COP)and Chevron ( CVX).
BearishCramer was bearish on PF Chang's China Bistro ( PFCB), Comtech Telecommunications ( CMTL), USEC ( USU), HCA ( HCA), Bronco Drilling ( BRNC)and ViroPharma ( VPHM). For more of Cramer's insights during the most recent Lightning Round,
Want more Cramer? Check out Jim's rules and commandments for investing from his latest book by clicking here.